Get the Stockscreener App
1.12
2.75%
0.03
After Hours:
1.07
-0.05
-4.46%
Callan Jmb Inc stock is traded at $1.12, with a volume of 42,425.
It is up +2.75% in the last 24 hours and down -15.79% over the past month.
Callan Jmb Inc is a vertically integrated logistics and fulfillment company that provides cryogenic logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology, and specialized cold chain logistics know-how. It provides a system that utilizes predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity and to provide immediate response in industries while ensuring environmental responsibility. The company views its solutions as disruptive to the older technologies of dry ice and liquid nitrogen in that its solutions are comprehensive and combine its competencies in configurations that are customized to its clients.
See More
Previous Close:
$1.09
Open:
$1.1
24h Volume:
42,425
Relative Volume:
0.14
Market Cap:
$6.30M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+16.67%
1M Performance:
-15.79%
6M Performance:
-71.65%
1Y Performance:
-77.78%
1-Day Range:
$1.06
$1.13
1-Week Range:
$0.8563
$1.22
52-Week Range:
$0.8563
$5.88
Callan Jmb Inc Stock (CJMB) Company Profile
Name
Callan Jmb Inc
Sector
Industry
Phone
(830) 438-0395
Address
244 FLIGHTLINE DRIVE, SPRING BRANCH
Compare CJMB vs FDX, UPS, JBHT, EXPD, CHRW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CJMB
Callan Jmb Inc
|
1.12 | 6.13M | 0 | 0 | 0 | 0.00 |
FDX
Fedex Corp
|
362.75 | 85.37B | 91.93B | 4.48B | 4.37B | 18.79 |
UPS
United Parcel Service Inc
|
98.07 | 81.83B | 88.64B | 5.57B | 4.77B | 6.5569 |
JBHT
J B Hunt Transport Services Inc
|
243.04 | 22.48B | 12.13B | 622.10M | 1.03B | 6.4596 |
EXPD
Expeditors International Of Washington Inc
|
153.08 | 18.58B | 11.07B | 812.05M | 953.40M | 5.9494 |
CHRW
C H Robinson Worldwide Inc
|
167.13 | 19.01B | 16.20B | 599.01M | 807.11M | 4.9434 |
Callan Jmb Inc Stock (CJMB) Latest News
CJMB (Callan JMB) outlines strategic operational upgrades to boost multi-segment revenue growth over coming quarters.Certified Trade Ideas - Newser
Callan JMB (CJMB) Stock: Why Revenue Growth (Institutional Demand) 2026-04-22Shared Trade Alerts - Newser
CJMB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Callan JMB Inc. plans 150-acre campus in Marion - Business Alabama Magazine
Callan JMB plans 150-acre pharmaceutical campus in Alabama By Investing.com - Investing.com India
Callan JMB plans 150-acre pharmaceutical campus in Alabama - Investing.com
Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC - marketscreener.com
Callan JMB Launches The Atlas Complex in Alabama to Successfully Achieve the Capture of Significant Pharmaceutical Onshoring Demand and Expand U.S. Supply Chain Infrastructure - The Manila Times
Callan JMB Launches The Atlas Complex in Alabama to - GlobeNewswire
Callan JMB faces patent infringement lawsuit in Texas By Investing.com - Investing.com Australia
Callan JMB faces patent infringement lawsuit in Texas - Investing.com
Callan JMB Inc. Responds to Lawsuit Filed by Eddie Patent Holdings, LLC - Quiver Quantitative
Callan Jmb Complaint Filed By Eddie Patent Holdings Does Not Impact Operations, Strategic Partnerships, Or Ongoing Projects - TradingView
Investment Report: What drives Callan JMB Incs stock price2026 Closing Moves & Reliable Price Breakout Signals - baoquankhu1.vn
Earnings Miss: Is Callan JMB Inc stock a buy or sell2026 Intraday Action & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Callan JMB Inc. Files Form 8-K with SEC: Company Details, Address, and NASDAQ Listing Information - Minichart
Callan JMB Receives Nasdaq Deficiency Notice on Equity - TipRanks
Callan JMB Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Growth Report: Is Callan JMB Inc forming a bullish divergence2026 Winners & Losers & Technical Pattern Alert System - baoquankhu1.vn
Is Callan JMB (CJMB) Stock defensive in downturns | Price at $1.19, Down 1.65%Expert Momentum Signals - Newser
Aug Update: Does Callan JMB Inc align with a passive investing strategy2026 Outlook & Verified Swing Trading Watchlists - baoquankhu1.vn
Is Callan JMB (CJMB) Stock Moving Higher | Price at $1.29, Down 1.53%Beta Signals - Newser
Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer - Sahm
Callan JMB Accelerates Cross-Jurisdiction Vaccine Redistribution to Combat Localized Outbreaks - Healthcare Packaging
Aug Momentum: What drives Callan JMB Incs stock priceMarket Growth Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Callan JMB Successfully Deploys Rapid Redistribution of - GlobeNewswire
New Highs: Is Xylem Inc in a long term uptrend2026 Top Decliners & AI Driven Stock Movement Reports - baoquankhu1.vn
Callan Jmb (CJMB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
CJMB Stock Analysis: Callan JMB Inc. 7.26 Percent Gain to 1.33, Key Drivers Breakdown - Cổng thông tin điện tử tỉnh Tây Ninh
Callan JMB Reports Full Year 2025 Financial Results and Provides Business Update - The Manila Times
EV Market: What drives Callan JMB Incs stock priceIPO Watch & Verified Technical Signals - baoquankhu1.vn
Callan JMB to oversee manufacturing for JKB-122 immune platform By Investing.com - Investing.com South Africa
12 Industrials Stocks Moving In Friday's Intraday Session - Benzinga
Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement - globenewswire.com
Top Executive Makes Bold Insider Move at Callan JMB, Inc. - TipRanks
Croyle David J, chief medical officer, buys $17841 in Callan JMB Inc. - Investing.com UK
Market Review: What drives Callan JMB Incs stock price2026 Rallies & Fast Moving Stock Trade Plans - baoquankhu1.vn
Volume Summary: Does Callan JMB Inc align with a passive investing strategy - baoquankhu1.vn
Callan JMB files to sell 6M shares of common stock for holders - MSN
Callan JMB Amends Equity Purchase Agreement with Hexstone - The Globe and Mail
Callan JMB to oversee manufacturing for Long COVID drug trial By Investing.com - Investing.com South Africa
Callan JMB to oversee manufacturing for Long COVID drug trial - Investing.com
Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech's IND Clinical Trials for lodonal in the Treatment of Long COVID - Bitget
Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech’s IND Clinical Trials for lodonal™ in the Treatment of Long COVID - The Globe and Mail
Croyle David J, chief medical officer, buys Callan JMB (CJMB) shares - Investing.com UK
Callan Jmb Inc Stock (CJMB) Financials Data
There is no financial data for Callan Jmb Inc (CJMB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):